Lung Cancers Completed Phase 2 Trials for Aldesleukin (DB00041)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00019331Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsTreatment
NCT00019084Vaccine Therapy and Biological Therapy in Treating Patients With Advanced CancerTreatment
NCT00003125Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced TumorsTreatment